Faculty

Sebastian S. Lopez Chiriboga, M.D.

Clinical Studies

The Center for Multiple Sclerosis and Autoimmune Neurology (CMSAN) Research Procedures (CMSAN) Rochester, Minn., Jacksonville, Fla.
The purpose of this study is to find and identify autoreactive lymphocytes including autoantibody producing B cells and autoreactive T-cells.

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants with Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis (AIE001) Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.
The purpose of the study is to assess the efficacy of rozanolixizumab as measured by seizure freedom, change in cognitive function, use of rescue medication, onset of seizure freedom and to assess safety and tolerability.
The Center for Multiple Sclerosis and Autoimmune Neurology (CMSAN) Biorepository Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.
The purpose of this study is to establish a repository consisting of clinical information, radiological data, serum, peripheral blood lymphocytes, plasma, cerebrospinal fluid (CSF), urine, stool, DNA and tissue specimens collected from patients who have central nervous system (CNS) inflammatory diseases.